Glucophage Trio
Type 2 Diabetes Mellitus
1mg + 0.2mg + 500mg
Glimepiride and metformin tablets for type 2 diabetes. Glimepiride triggers insulin release, metformin cuts the liver's sugar output.
From$1.25/ tabletView
Voglibose
Voglibose is an alpha-glucosidase inhibitor used to manage blood sugar in type 2 diabetes. It is listed as Glucophage Trio, a single tablet combining three active ingredients.
Key points
- Voglibose slows the digestion of carbohydrates, reducing the blood sugar spike that follows a meal.
- Glucophage Trio is the only product in this catalogue, combining voglibose with glimepiride and metformin in one tablet.
- Voglibose may cause digestive side effects such as bloating or diarrhoea, particularly when treatment begins.
Voglibose is an alpha-glucosidase inhibitor, which means it slows the enzymes that break down carbohydrates in the gut. This delays the absorption of sugar after a meal, keeping blood glucose levels from rising too high. The single tablet in this catalogue combines voglibose with glimepiride and metformin, so one dose addresses several aspects of blood-sugar control at once.